Update on Eudamed and its implications for vigilance in the EU

This will be a very short post, because everything I could write down on the subject is in the interview I had with Ashley Yeo of Scrip Regulatory Affairs, that kindly consented to publication of the article on my website, so here it is. It puts current and future vigilance initiaties, including the Eudamed database, in the perspective of the ongoing fall-out of the PIP scandal and contains some speculative predictive statements about where things are going.


Navigate through our knowledgebase

Related articles

Article

Counting down to the MDR date of application, and the legal stuff to get right before May 2020

Do you know that feeling that things look far away, but when you think about it are a lot closer than you think? This is the feeling that the first medical devices…

Read more

Article

Seminar MDR & IVDR Implementation Countdown – slides

191002-Erik Vollebregt-MDR Countdown 191002-Paul van Geffen- Last elements before implementation 191002-Sue Spencer – IVDR Executive summary 191002-Ronald Boumans- Latest on Eudamed

Article

Trends from Silicon Valley for meat alternatives

What does the future of our meat look like? This topic was the subject of the Annual Conference of the Good Food Institute (GFI), which took place in San Francisco last month. GFI is an American non-profit organization that works with entrepreneurs, scientists and investors to make groundbreaking good food a reality. GFI focuses on […]